Tests help identify potential convalescent plasma donors
June 17, 2020

QualTex Laboratories is up and running with two assays to detect the presence of COVID-19 antibodies in the bloodstream.

QualTex Laboratories, a subsidiary of nonprofit BioBridge Global, has been performing the SARS-CoV-2 IgG Antibody ELISA assay since April. A second assay, the Abbott Laboratories Architect Antibody assay, went into full-scale production for a QualTex customer on June 8.

“These two assays are part of our continuing commitment to public health,” said Ward Carter, Chief Operating Officer of QualTex Laboratories. “They give blood centers the information to potentially save lives during the COVID-19 pandemic by helping to identify potential COVID-19 convalescent plasma donors.”